Ginkgo Bioworks and OpenAI Collaborate to Reduce Protein Synthesis Costs by 40%

Ginkgo Bioworks Holdings and OpenAI have collaborated to design an AI system that can reduce costs in cell-free protein synthesis by 40%. This approach differs from DNA-based protein synthesis, which can rapidly produce proteins but is often expensive. The collaboration aims to make protein synthesis more efficient and cost-effective for various industries.